StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) stock

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.28−0.00 (-0.74%)

Close on Nov 17, 2026Market cap $53.58MP/E –Yield –

Heron Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Heron Therapeutics's EV/EBITDA was 42.2× on Jan 30, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202642.2×+0.9
2025Dec 31, 202541.4×–

More Heron Therapeutics figures

See a number that looks wrong?